Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 16, 2011

Premium

Alnylam Pharmaceuticals has appointed Akshay Vaishnaw to the newly created position of chief medical officer.

Vaishnaw was previously senior vice president of clinical research at Alnylam. Before that, he was senior director of translational medicine at Biogen Idec.


Mirna Therapeutics has appointed Art Krieg as a scientific advisor.

Krieg is currently an entrepreneur in residence at venture capital firm Atlas Ventures. Before this, he served as CSO of Pfizer's oligonucleotide therapeutics unit, which was recently shut down as part of a corporate restructuring.

He was also the CSO and co-founder of Coley Pharmaceuticals, which was acquired by Pfizer in 2008.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.